They are all reasonable concerns.
The other reason for clamping the sp might be that someone is thinking about a strategic investment so it would be in their interests to keep the sp low until that's negotiated. They will bring cash and own a chunk of the company.
The timing for the FDA application and the German trial might then be positive in that case - it might mean that even after the dilution that will come with a strategic partnership, the sp will get a lift with either or both outcomes (like China Grand and Telix). The company is pretty clear that the German trial, in particular, will bring a significant amount of revenue to the company.
So, if a deal is done in late November and those FDA/German milestones are achieved in the 3rd quarter, it might work out well for current holders.
- Forums
- ASX - By Stock
- OSL
- Ann: Entitlement Offer to raise up to $9.9 million
Ann: Entitlement Offer to raise up to $9.9 million, page-127
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.38M |
Open | High | Low | Value | Volume |
0.5¢ | 0.6¢ | 0.5¢ | $71.81K | 11.98M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 10730612 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 9523384 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 10730612 | 0.005 |
28 | 23313949 | 0.004 |
11 | 11756631 | 0.003 |
6 | 5457516 | 0.002 |
5 | 7800001 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 9523384 | 12 |
0.007 | 27418167 | 24 |
0.008 | 11723848 | 10 |
0.009 | 12462253 | 5 |
0.010 | 7693666 | 6 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |